Search

everythinglearnresearchcommunity

for

Search:↓

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

A 589 nm laser increases IL-2 and IFN-y gene expression in human T-cells.

Transplanted hair follicles can change and adapt to new areas of the body, with the immune system possibly playing a role in this adjustment.

The AVET system effectively delivers genes to human keratinocytes and may help treat skin diseases.

A parasite molecule can speed up skin healing and reduce scarring.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Patients with skin immune diseases need better education on UV protection to improve compliance.

IL-1 receptor absence in mice leads to skin cysts and changes in immune response after UVB exposure.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

Methylprednisolone helps skin cells stick together better in pemphigus vulgaris.

The peptide IMT-P8 can effectively deliver proteins into the skin and cells for potential skin treatments.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

The nail matrix has a reduced immune response, protecting it from autoimmunity.